NCT01719484

Completed

Functional MRI of Stress in Obesity

Yale University Source

Compare

Other study identifiers

Sponsor study identifier

0805003899

Study Type

observational

Actual enrollment (reported)

50

Locations

1 country

Sites

1

Timeline

Study Start

May 2008

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

March 2014

Actual (reported)

Study Completion

March 2014

Actual (reported)

Brief Summary

To examine the influence of obesity on brain activation during food cue, stress, and neutral relaxing conditions

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 50 participants
Study completion date: March 2014
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
May 2008
Date type not reported
This date has not been verified as actual or estimated.
First Submitted
October 29, 2012
Actual (reported)
First Posted
November 1, 2012
Actual (reported)
Primary Completion
March 2014
Actual (reported)
Study Completion
March 2014
Actual (reported)

Last Updated: July 13, 2022
Status Verified: July 2022
Last Update Submitted: July 11, 2022

Conditions

Obesity

Outcome Measures

Primary Outcomes (1)

No outcome measures for this study, this is an imaging study only
Upon study completion

Study Arms (2)

Healthy

Subjects deemed to be medically healthy

Obese

Subjects deemed to be medically obese

Eligibility Criteria

Age18 Years - 50 Years

Sexall

Healthy VolunteersYes

Age GroupsAdult (18-64)

Sampling MethodProbability Sample

Study Population

30 obese subjects and 30 matched healthy controls will be recruited for this study.

You may qualify if:

Between ages 18-50 years old.

Sponsors & Collaborators

Yale University
Otherlead

Study Sites (1)

Yale University School of Medicine

New Haven, Connecticut, 06519, United States

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

Marc N Potenza, MD, PhD
Yale University
PRINCIPAL INVESTIGATOR

Enrollment

50 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: CASE CONTROL
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

October 29, 2012

First Posted

November 1, 2012

Study Start

May 2008

Date type not reported

This date has not been verified as actual or estimated.

NCT04779697

GLP-1 Analogue Effects on Food Cues, Stress, Motivation for Highly Palatable Foods, and Weight

Phase 1Completed

NCT00712127

Re-energize With Nutrition, Exercise and Weight Loss

Not ApplicableCompleted

NCT00484172

Genomic Search for Childhood Obesity Genes-A Pilot Study

Withdrawn

NCT00610025

Minimally Invasive Trocar Placement in Obesity Surgery

Not ApplicableCompleted

NCT00752908

Tissue Penetration of Antibiotics in Obesity

Completed

NCT01442142

A Study to Determine the Effectiveness of a Self-regulation Program to Treat Pediatric Obesity

Not ApplicableCompleted

Able to read and write.

negative urine toxicology screens during intake appointments indicating no history of current or past dependence on alcohol or illicit drug use.

WOMEN: have a regular menstrual cycle.

BMI: 30 \< BMI \< 35 for obese subjects (upper limit of 35 selected given our experience with heavier individuals fitting comfortably in the fMRI scanner) and 18.5 \< BMI \<25 for normal weight subjects (Institute, 2006)

You may not qualify if:

any major neurological illness or injury and any current or prior clinically significant mental health (including PTSD) or substance use disorder (with exception of nicotine dependence) as determined by SCID interview;
Regular use of any psychoactive drugs including anxiolytics and antidepressants.
Any significant current medical condition such as neurological, cardiovascular, endocrine, renal, liver, thyroid pathology; subjects on medications for any medical condition will be excluded.
Any subjects with foreign ferromagnetic metal objects in their body or other MR contraindications will be excluded including subjects who work as welders.
Women on oral contraceptives, peri- and post-menopausal women, and pregnant or lactating women (as alterations in stress response are associated with these states).

Contact the study team to confirm eligibility.

Primary Completion

March 2014

Actual (reported)

Study Completion

March 2014

Actual (reported)

Last Updated

July 13, 2022

Record last verified: 2022-07

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT01719484
Data provider: ClinicalTrials.gov
Source updated: 2022-07-13
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:23:20 UTC

Locations

US(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Study Arms (2)

Healthy

Obese

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations